-

Tivic Health CEO Jennifer Ernst to Speak at Sidoti Micro Cap Virtual Conference on December 8

SAN FRANCISCO--(BUSINESS WIRE)--Tivic Health Systems, Inc. (Nasdaq: TIVC), a commercial-phase bioelectronic medicine company, today announced that CEO Jennifer Ernst will present a corporate overview at the Sidoti Micro Cap Conference taking place virtually, December 8-9, 2021.

Ms. Ernst is scheduled to discuss the rapidly growing field of bioelectronic medicine and will participate in one-on-one meetings with investors during the event. Her virtual presentation will take place:

Sidoti Micro Cap Conference
Date: Wednesday, December 8, 2021
Time: 3:15 pm ET / 12:15 pm PT

Registration is mandatory for conference participation. For information on the Sidoti Micro Cap Conference or to register visit https://www.sidoti.com. To arrange a meeting with Ms. Ernst contact IR@TivicHealth.com.

About Tivic Health Systems, Inc.

Tivic Health Systems, Inc. is a commercial-phase healthtech company advancing bioelectronic medicine to deliver non-invasive solutions that treat disease, increase wellness and improve lives. Visit https://tivichealth.com.

Forward Looking Statements

This press release contains “forward-looking statements” that are subject to substantial risks and uncertainties. All statements, other than statements of historical fact, contained in this press release are forward-looking statements. Forward-looking statements contained in this press release may be identified by the use of words such as “anticipate,” “believe,” “contemplate,” “could,” “estimate,” “expect,” “intend,” “seek,” “may,” “might,” “plan,” “potential,” “predict,” “project,” “target,” “aim,” “should,” “will” “would,” or the negative of these words or other similar expressions, although not all forward-looking statements contain these words. Forward-looking statements are based on Tivic Health Systems, Inc.’s current expectations and are subject to inherent uncertainties, risks and assumptions that are difficult to predict and include statements regarding the expected use of proceeds and expected closing. Further, certain forward-looking statements are based on assumptions as to future events that may not prove to be accurate. These and other risks and uncertainties are described more fully in the section titled “Risk Factors” in the final prospectus related to the public offering filed with the Securities and Exchange Commission. Forward-looking statements contained in this announcement are made as of this date, and Tivic Health Systems, Inc. undertakes no duty to update such information except as required under applicable law.

Contacts

Cheryl Delgreco
Cheryl.Delgreco@tivichealth.com
617-429-6749

Tivic Health Systems, Inc.

NASDAQ:TIVC

Release Versions

Contacts

Cheryl Delgreco
Cheryl.Delgreco@tivichealth.com
617-429-6749

Social Media Profiles
More News From Tivic Health Systems, Inc.

Tivic Expands Intellectual Property Portfolio

FREMONT, Calif.--(BUSINESS WIRE)--Tivic Health® Systems, Inc. (Nasdaq: TIVC), a diversified therapeutics company, today announced it is expanding its intellectual property portfolio with the recent filing of two additional patent applications with the United States Patent and Trademark Office. The first application applies to Tivic’s TLR5 agonist portfolio, which includes Entolimod and Entolasta. The patent titled “Immunomodulatory Pathway Modifying Agents and Uses of Same for Cancer Therapy” r...

Tivic Health to Report Third Quarter 2025 Financial Results on November 14th Via Conference Call and Webcast

FREMONT, Calif.--(BUSINESS WIRE)--Tivic Health® Systems, Inc. (Nasdaq: TIVC), a diversified immunotherapeutics company, today announced that it will report its third quarter results for 2025 via pre-recorded conference call and webcast on Friday, November 14, 2025 at 1:30 PM PT / 4:30 PM ET. Teleconference Details: Toll Free: 888-506-0062 International: 973-528-0011 Participant Access Code: 230582 Webcast Link https://www.webcaster5.com/Webcast/Page/2865/53145 About Tivic Health Systems, Inc. T...

Tivic CEO, Jennifer Ernst, to Join Panel at 8th Annual Northwell Health Innovation Constellation Forum on Thursday, Oct. 23

FREMONT, Calif.--(BUSINESS WIRE)--Tivic Health® Systems, Inc. (Nasdaq: TIVC), a diversified immunotherapeutics company, today announced that CEO, Jennifer Ernst, will participate in the eighth annual Constellation Forum, a global conversation on Bioelectronic Medicine. She will join other leaders in the field to discuss the opportunities for advancing bioelectronic medicine. When: Thursday, Oct. 23, at 11:55 a.m. ET/8:55 a.m. PT Panel Title: Building a Big Tent Bioelectronic Medicine stands to...
Back to Newsroom